Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 05/11

Trade details

Type
Insider sale
Amount
$1,138,507.32
Shares · price
2,022 sh · $563.06 a share
Held after
46,865 sh
Trade date
26/05/08
Filed
26/05/11
Days to filing
3 days

Sold 4.1% of holdings

Share of holding sold
4.1%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 04/08~06/07

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $262.3K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $1.1M of United Therapeutics UTHR · 4.1% of holdings · 10b5-1 plan | Whalegun